Three-Dimensional-Bioprinted Embedded-Based Cerebral Organoids: An Alternative Approach for Mini-Brain In Vitro...

Area of Science:

• Neuroscience
• Biotechnology
• Stem Cell Biology

Background:

• Cerebral organoids (cORGs) from induced pluripotent stem cells (iPSCs) are vital for studying human neurophysiology, disease modeling, and drug discovery.
• Current methods rely on manual Matrigel embedding, facing challenges in reproducibility, cost, scalability, and operator dependency.
• These limitations hinder the broad application and translational potential of iPSC-derived brain organoids.

Purpose of the Study:

• To develop a novel, operator-independent method for generating cerebral organoids.
• To address the limitations associated with manual Matrigel embedding in current organoid protocols.
• To create a scalable and reproducible approach for brain organoid generation.

Main Methods:

• A chemically defined hydrogel bioink was formulated using Matrigel diluted with sodium alginate (SA) and sodium carboxymethylcellulose (CMC).
• Neural embryoid bodies (nEBs) were 3D bioprinted using this SA-CMC-Matrigel hydrogel.
• Immunohistochemistry, immunofluorescence, and gene expression analyses were performed to characterize the organoids.

Main Results:

• The SA-CMC-Matrigel hydrogel successfully supported the generation of iPSC-derived cortical cORGs, comparable to conventional Matrigel methods.
• Hydrogel-based 3D-bioprinted cORGs exhibited consistent, heterogeneous masses by day 40 of differentiation.
• Organoids displayed cytoarchitecture resembling early fetal brain development, with neural progenitor cells (PAX6+/Ki67+) and neuronal layer formation (SYP+).

Conclusions:

• The novel hydrogel-based 3D bioprinting technique provides a reproducible and scalable alternative for cerebral organoid generation.
• This method overcomes the operator dependency and limitations of traditional Matrigel embedding.
• The generated organoids mimic early cortical development, offering a promising platform for neurobiological research and therapeutic development.